Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.
about
Clinical Practices and Outcomes on Chemotherapy-Induced Nausea and Vomiting Management in South Korea: Comparison with Asia-Pacific Data of the Pan Australasian Chemotherapy Induced Emesis Burden of Illness Study.Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy.A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab.NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron.Addressing the value of novel therapies in chemotherapy-induced nausea and vomiting.Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines.Stability of azasetron-dexamethasone mixture for chemotherapy-induced nausea and vomiting administration.Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses.
P2860
Q31045439-F269EFFE-E105-4AB7-BCD2-24C8A8D27787Q34166946-7FFB3A27-D327-415E-869B-7E8F63937166Q37551843-C2DB997C-C000-4F6D-81E0-02BE76139E93Q37660556-8B520FB8-48BC-44BB-83F6-38904F5A8E7DQ38250191-062CDE00-0DA4-46A1-A11D-D00DD6B0DCDCQ38631646-9DAF7919-6ABE-4913-97DA-E0B087169C70Q47129972-12CF176B-20FC-432D-82C3-FC79ED8949DDQ48127109-64341DE8-2D03-4B64-80C0-8E90E19AC2B7
P2860
Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Adherence to antiemetic guidel ...... nslate evidence into practice.
@ast
Adherence to antiemetic guidel ...... nslate evidence into practice.
@en
type
label
Adherence to antiemetic guidel ...... nslate evidence into practice.
@ast
Adherence to antiemetic guidel ...... nslate evidence into practice.
@en
prefLabel
Adherence to antiemetic guidel ...... nslate evidence into practice.
@ast
Adherence to antiemetic guidel ...... nslate evidence into practice.
@en
P2093
P2860
P1476
Adherence to antiemetic guidel ...... nslate evidence into practice.
@en
P2093
James E Herndon
Mary Lou Affronti
Susan M Schneider
Susan Schlundt
P2860
P2888
P304
P356
10.1007/S00520-014-2136-0
P577
2014-02-26T00:00:00Z